Fujirebio

Fujirebio is a Japanese multinational biotechnology company, founded and headquartered in Tokyo, Japan, and present locally with offices in Japan, Asia, Europe and the United States and through a large international distribution network. The company has manufacturing facilities in Japan, Europe and the United States.

Content by Fujirebio

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

Fujirebio | | 2 min read

Page 1 of 1 - 1 Total Items

Image of small blue creatures called Nergals. Some have hearts above their heads, which signify friendship. There is one Nergal who is sneezing and losing health, which is denoted by minus one signs floating around it.

June 2025, Issue 1

Nergal Networks: Where Friendship Meets Infection

A citizen science game explores how social choices and networks can influence how an illness moves through a population.

View this Issue

Research Resources

Podcasts

Webinars

Videos

Infographics

eBooks

An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

By fine-tuning polishing conditions, scientists attain high titers of infectious lentiviral particles during purification.

Unraveling Complex Biology with Advanced Multiomics Technology

Unraveling Complex Biology with Five-Dimensional Multiomics

Learn how a next-generation platform accelerates biological research by enabling high-throughput, spatially resolved multiomics profiling.

Resurrecting Plant Defense Mechanisms to Avoid Crop Pathogens

In this webinar, Imogen Binnian will share how AI and gene synthesis technology can accelerate the discovery and validation of novel disease traits.

Seeing and Sorting with Confidence

Real-time imaging enhances fluorescence activated cell sorting (FACS) to help scientists overcome the cost and burden of validation.

Alamar Biosciences, Alzheimer's Disease Data Initiative, and Gates Ventures Unite in Global Partnership to Advance Translational Research in Alzheimer's Disease

Multi-center project will profile over 40,000 samples using ultra-sensitive NULISA™ technology.